Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity
중증 비만 환자의 SARS-CoV-2 백신에 대한 항체 반응
Article
[키워드] age
antibody
antibody level
antibody levels
Antibody Response
Antibody titer
Antibody titers
anticipated
Antigen
blood sample
Blood samples
BMI
BNT162b2
BNT162b2 mRNA
BNT162b2 vaccine
BNT162b2 vaccines
consecutive patient
Control
control group
CoronaVac
Course
COVID-19
COVID-19 vaccination
determined by
disease
domain
dose
dose of vaccination
Effectiveness
enrolled
female
IgG antibody
IgG antibody titers
inactivated
individual
Infection
information
male
mRNA
normal weight
not significantly different
obesity
of BNT162b2
Patient
presenting
Quantitative
recruited
reduced
response
SARS-CoV-2
SARS-CoV-2 IgG
SARS-CoV-2 IgG antibody
SARS-COV-2 infection
SARS-CoV-2 spike antigen
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
serological
Severe obesity
significantly
significantly higher
significantly lower
spike-protein
subject
vaccination
Vaccine
Vaccines
vulnerable population
was performed
weight control
were measured
[DOI] 10.1007/s11695-022-06181-y PMC 바로가기 [Article Type] Article
[DOI] 10.1007/s11695-022-06181-y PMC 바로가기 [Article Type] Article